TAC3 and cancer: It is suggested that overexpression of NK-3R in cancer cells in the invasion front leads to upregulation of the NK-3R signal, rather than the NKB ligand rising at the tumor invasion front due to increased lymphovascular and perineural invasion (Figure 5).